00866nas a2200289   4500000000100000000000100001008004100002653002700043653003800070653004600108653002500154653004600179100001500225700001500240700001500255700001900270700001100289700001600300700001300316700001600329700001600345700001400361700001500375245015700390250001500547020001400562       2022                            d10aAnaphylactic reactions10aDipeptidyl peptidase-4 inhibitors10aGlucagon-like peptide-1 receptor agonists10apharmacoepidemiology10aSodium-glucose cotransporter-2 inhibitors1 aR. Pradhan1 aE. Patorno1 aH. Tesfaye1 aS. Schneeweiss1 aH. Yin1 aJ. Franklin1 aA. Pawar1 aC. Santella1 aO. H. Y. Yu1 aC. Renoux1 aL. Azoulay00aGlucagon-Like Peptide-1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: Multisite Population-Based Cohort Study  a2022/02/10  a0002-9262